| 일반논문 |
2025-06-26 |
JAK2 Inhibition Augments the Anti-Proliferation Effects by AKT and MEK Inhibition in Triple-Negative Breast Cancer Cells |
| 일반논문 |
2025-06-04 |
A review on ribosomal protein S3 (RPS3): Roles in cancer and its resistance to drugs |
| 일반논문 |
2025-04-28 |
Therapeutic implication of oxidative stress-induced growth inhibitor 1 (OSGIN1) in cancer |
| 일반논문 |
2025-03-01 |
Structure-activity relationship analysis of mono-methylated quercetins by comprehensive MS/MS analysis and anti-proliferative efficacy in human colorectal cancer cells
|
| 일반논문 |
2025-01-30 |
Identification of sinensetin as a selective inhibitor for mitogen-activated protein kinase kinase 6 and an anticancer agent for non-small cell lung cancer |
| 일반논문 |
2023-09-01 |
TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1A |
| 일반논문 |
2023-08-30 |
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non‑small cell lung cancer |
| 일반논문 |
2023-08-24 |
Beta-Transducin Repeats-Containing Proteins as an Anticancer Target |
| 일반논문 |
2023-06-01 |
Extracellular Vesicles as a New Therapeutic Entity |
| 일반논문 |
2023-02-01 |
Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells |
| 일반논문 |
2022-10-01 |
Inhibition of I kappa B Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells
|
